PUBLICATION

Pharmaceutical Technology

AUTHORS

Ozgur Erguney, Sam Joll, Miyese Ozcan

Belgium Pharmaceuticals 2009 Pharmaceutical Technology Release

September 02, 2009

Belgium is one of the largest centers for pharmaceutical distribution and has the second highest number of pharmaceuticals exports per capita worldwide. In addition to attracting foreign companies, the country has also produced its own international heavyweights. But how will this small European country fare against its neighboring European giants and will it survive the threat of the emerging players as the global pharmaceutical industry faces turbulent times?

RELATED INTERVIEWS MORE INTERVIEWS

Powered by its XmAb antibody engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat autoimmune disorders, cancer, asthma and allergic diseases.
Piramal Pharma updates GBR in its recent developments and prospects.
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.

RECENT PUBLICATIONS

Latin America Chemical Week Report 2024

The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.

MORE PREVIOUSLY PUBLISHED

MACIG

"Zambia indeed deterred many investors due to multiple policy shifts in the mining tax regime that showed no consistency. However, since 2021 and with a new government in place, we have seen more stability as well as investor-friendly policies."

SUBSCRIBE TO OUR NEWSLETTER